Bone marrow - nonneoplastic
Alterations in cellularity
Hypercellularity


Topic Completed: 1 October 2013

Revised: 22 July 2019

Copyright: 2002-2019, PathologyOutlines.com, Inc.

PubMed Search: Bone marrow hypercellular [title]

Dragos C. Luca, M.D.
Page views in 2018: 4,173
Page views in 2019 to date: 3,736
Cite this page: Luca DC. Hypercellularity. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/bonemarrowhypercellularmarrow.html. Accessed October 21st, 2019.
Definition / general
  • A finding, not a diagnosis
  • Usually reactive (infection, blood loss) but also other benign or malignant causes
Etiology
  • Benign causes:
    • Affecting predominantly one hematopoietic line:
      • Erythroid hyperplasia: often due to hemolytic anemia, high altitude or hypoxia of any other cause, renal disease, hemoglobinopathies, familial polycythemia
      • Myeloid hyperplasia: infections, compensatory hyperplasia after cell destruction, chronic blood loss, other stressors, drugs (G-CSF)
      • Megakaryocytic hyperplasia: often due to immune thrombocytopenia but also other types of thrombocytopenia; megakaryocytes may have striking nuclear changes
  • Malignant causes:
    • Affecting predominantly one hematopoietic line:
      • Erythroid: polycythemia vera, dysregulated erythropoietin production by various neoplasms
      • Myeloid: myeloid neoplasms (AML, CML, MDS, other MPD besides CML)
      • Megakaryocytic: MPD (essential thrombocythemia, CML, primary myelofibrosis), acute megakaryoblastic leukemia
  • Other causes include lymphoma, metastases
Microscopic (histologic) description
  • Increased hematopoiesis
  • Reduced adipose tissue
Microscopic (histologic) images

Images hosted on other servers:

Megaloblastic anemia

Back to top